Medical News and Perspectives
April 27, 2005

Will Lung Cancer Targeting Hit Its Mark?

JAMA. 2005;293(16):1963-1964. doi:10.1001/jama.293.16.1963

San Diego—For the cancer that claims more lives than any other, the past year was noteworthy in terms of both research and therapy. Although more than 150 000 people in the United States die of lung cancer each year, new studies are making strides toward improving tumor response and prolonging survival for patients. At the American Association for Cancer Research’s recent conference, “Molecular Pathogenesis of Lung Cancer: Opportunities for Translation to the Clinic,” researchers discussed the latest findings and ongoing studies.